Europe Active Pharmaceutical Ingredients (API) Market

Europe Active Pharmaceutical Ingredients (API) Market Size, Share, Growth Analysis, By Type of Synthesis(Biotech, Synthetic), By Type Outlook(Generic API, Innovative API), By Type of Drug(Prescription Drugs, Over-the-counter (OTC) Drugs), By Application Outlook(Cardiovascular Diseases, Oncology), By Region/Country(U.K., Germany) - Industry Forecast 2024-2031


Report ID: UCMIR35I2324 | Region: Regional | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

Europe Active Pharmaceutical Ingredients (API) Market Insights

Market Overview:

The European market for active pharmaceutical ingredients (API) was valued at approximately USD 42.64 billion in 2022, and it is projected to experience a compound annual growth rate (CAGR) of 5.75% from 2023 to 2030. This growth is primarily attributed to advancements in the development of API, the expansion of the biopharmaceutical sector, and the establishment of state-of-the-art manufacturing facilities capable of producing complex pharmaceutical products. As an illustration, in July 2022, Wacker made a substantial investment of over USD 110 million to enhance its German facility by creating a new mRNA Competence Center dedicated to the production of active drug substances like mRNA-based coronavirus vaccines.

Europe Active Pharmaceutical Ingredients (API) Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Pharmaceuticals by segment aggregation, the contribution of the Pharmaceuticals in Pharmaceuticals, Biotechnology & Life Sciences and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The market for Europe Active Pharmaceutical Ingredients (API) was estimated to be valued at US$ XX Mn in 2021.

The Europe Active Pharmaceutical Ingredients (API) Market is estimated to grow at a CAGR of XX% by 2028.

The Europe Active Pharmaceutical Ingredients (API) Market is segmented on the basis of Type of Synthesis, Type Outlook, Type of Drug, Application Outlook, Region/Country.

Based on region, the Europe Active Pharmaceutical Ingredients (API) Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the Europe Active Pharmaceutical Ingredients (API) Market are , Cipla, Inc. , Merck & Co., Inc. , Boehringer Ingelheim International GmbH , Sun Pharmaceutical Industries Ltd. , AbbVie, Inc. , Bristol-Myers Squibb Company , Teva Pharmaceutical Industries Ltd. , Albemarle Corporation , Aurobindo Pharma , Viatris Inc..

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Europe Active Pharmaceutical Ingredients (API) Market

Product ID: UCMIR35I2324

$5,300
BUY NOW GET FREE SAMPLE